179 - Annual Dose of Sweetness: 2024 Updates from the American Diabetes Association Guidelines
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
Sean P. Kane, PharmD, BCPS
5 • 644 Ratings
🗓️ 5 March 2024
⏱️ 41 minutes
🧾️ Download transcript
Summary
In this recurring episode, we discuss the important updates from the 2024 American Diabetes Association Guidelines!
Key Concepts
- Tirzepatide is now recommended as one of the weight loss pharmacotherapy options along with semaglutide in patients with diabetes. The language for its use in comparison to insulin therapy has been updated similar to GLP-1RAs.
- The new hypoglycemia section in chapter 6 now houses all recommendations regarding screening, education, prevention, and treatment of hypoglycemia. The recommendation for prescribing glucagon has been clarified - regardless of type of diabetes, it is recommended that glucagon be prescribed to all patients using insulin or those who are at high risk with proper education of family members or caregivers.
- Teplizumab, a monoclonal antibody against CD30, is available for preventing progression of stage 2 type 1 diabetes to stage 3 type 1 diabetes. Guidelines have updated screening criteria for staging type 1 diabetes and recommends use of teplizumab in these patients.
- Other updates revolve around emphasis of using diabetes technology such as CGMs and AID for appropriate patients, clarified or strengthened screening recommendations for type 1 staging, peripheral arterial disease, bone mass density, etc., and emphasis on weight management alongside meeting glycemic goals.
References
- American Diabetes Association. Standards of Care in Diabetes - 2024. Diabetes Care. 2024;47(1):S1-S322. Available at: https://diabetesjournals.org/care/issue/47/Supplement_1.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions. |
| 0:11.0 | This podcast is provided by pharmacists and faculty members at Rosal Franklin University College of Pharmacy. |
| 0:17.0 | This podcast contains general information for educational purposes only. This is not professional |
| 0:22.4 | advice and should not be used in lieu of obtaining advice from a qualified health care provider. |
| 0:27.2 | And now on to the show. |
| 0:31.3 | Welcome to Helix Talk episode 179. I'm your co-host Dr. Kane. And I'm Dr. Patel. And the title of today's episode, |
| 0:38.6 | to not our surprise, is annual dose of sweetness, the 2024 updates from American Diabetes |
| 0:44.5 | Association guidelines. And Dr. Patel, I think this is an amazing episode every year that we do |
| 0:50.7 | this because it really highlights the fantastic work that the American Diabetes Association does where they go through all of this literature and update this really large document |
| 1:00.1 | in terms of how to best treat patients who have diabetes. So not only is surprising that, you know, |
| 1:06.1 | these scholars sit together and review plenty of literature that amounted over the year because, you know, |
| 1:12.8 | diabetes is pretty prevalent and so there's a lot of studies and related literature. |
| 1:17.1 | But this document is actually a live document. |
| 1:19.6 | So you download a 2024 standards of care as a PDF, but they might be making some changes |
| 1:26.8 | as they go along. So it's always a good idea |
| 1:29.5 | to bookmark the reference and access it through electronically because they might be making |
| 1:35.7 | some changes. So they call it the live document. And we do have that included in our show notes. |
| 1:41.0 | Well, Dr. Patel, if you had to pick one thing from the guidelines that was one of the |
| 1:44.7 | bigger updates, what do you think it would be? The biggest updates, being a pharmacist, |
| 1:50.0 | I know this is a very well-represented interdisciplinary organization, and, you know, the guidelines |
| 1:55.4 | are also very reflective of a multi-prong approach. And so there is a little bit for everybody from a pharmacist's perspective. |
| 2:03.6 | I felt that the medication changes such as, you know, specific inclusion of tersepartite, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Sean P. Kane, PharmD, BCPS, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Sean P. Kane, PharmD, BCPS and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.